What EYSZ does

Eysz, Inc. is a private, Piedmont, California-based digital health and medical device company founded in 2018 that has built the Eysz Hyperventilation Recorder (HV Recorder), an FDA-registered gamified mobile application designed to help clinicians objectively screen children for absence seizures and differentiate Childhood Absence Epilepsy (CAE) from ADHD in primary care and pediatric neurology settings. The underlying technology combines video-based eye-tracking with machine-learning algorithms trained on NIH- and NSF-funded clinical studies conducted at multiple Level 4 Epilepsy Centers; the company cites 100% sensitivity and 91% specificity to video EEG for absence seizures longer than seven seconds. The product guides healthcare providers through a hyperventilation procedure, records the encounter for clinical review, and produces automated reports on hyperventilation effort, time to first event, duration, and description of seizure events.

The business model is hardware/device sales of the FDA-registered Eysz HV Recorder to healthcare providers via a sales-led, consultative motion — the company website drives leads through a 'Book a Demo' call-to-action and Calendly scheduling, with no publicly disclosed pricing. Target customer segments are pediatricians and primary care physicians (primary), child neurologists (secondary), and hospitals and clinics, reflecting a vertical go-to-market focus on the ADHD/CAE diagnostic pathway recommended by American Academy of Pediatrics guidelines. Capital structure to date is heavily weighted toward non-dilutive grant funding (NIH SBIR Phase I/II and NSF SBIR Phase I/II across the DASEY, DASHER, and ACER studies), supplemented by a disclosed ~$1.95 million equity round in July 2020 led by HealthTech Capital with Sand Hill Angels and UCB. Leadership combines clinical credibility (a UCSF-trained epilepsy neurologist founder/CEO) with medical-device commercialization experience (COO with Siemens Healthineers/Varian/Omnicell background) and ML research depth (CTO with a UCSD PhD in signal extraction).

Name

EYSZ

Legal name

Eysz, Inc.

Website

https://eyszlab.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

EYSZ (Eysz, Inc.) is a private pediatric digital-health company whose FDA-registered Eysz HV Recorder uses video-based eye-tracking and machine learning to help clinicians differentiate Childhood Absence Epilepsy from ADHD in office settings.

Ownership category

akta.pro rank

Product category

Pediatric Neurology Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

Keywords

• Eye-tracking medical device
• Absence seizure screening
• Pediatric neurology diagnostics
• ADHD epilepsy differentiation
• Digital health platform

Headquarters

HQ city

Piedmont

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Eysz HV Recorder Device: Sale of FDA-registered medical device for absence seizure screening. The device is used in clinical settings by healthcare providers for in-office objective screening of absence seizures in children.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Eysz develops and sells the Eysz Hyperventilation Recorder (HV Recorder), an FDA-registered, gamified mobile medical device used by healthcare providers for objective in-office screening of absence seizures in children. The device guides a hyperventilation procedure through a mobile application while recording video, then applies proprietary eye-tracking algorithms to detect absence seizures with accuracy comparable to video EEG (100% sensitivity, 91% specificity for events >7 seconds).

Product overview

Eysz, Inc. offers a single unified medical device product: the Eysz HV Recorder, an FDA-registered gamified mobile application designed for objective in-office screening of absence seizures in children. The app differentiates between ADHD and Childhood Absence Epilepsy (CAE) by guiding healthcare providers through a hyperventilation procedure while recording video data for clinical analysis. The product integrates video recording, gamification elements for child engagement, and algorithm-based event detection to support pediatric neurology diagnostics.

Differentiator

Problem solved

Functional benefit

Brands

• Eysz HV Recorder: FDA Registered, gamified solution for objective in-office screening of absence seizures using hyperventilation-triggered eye-tracking technology.

Products and services

• Eysz HV Recorder (Hyperventilation Recorder) FDA-registered, gamified mobile medical device that guides healthcare providers through a hyperventilation procedure on pediatric patients while recording video for clinical review. Proprietary eye-tracking algorithms analyze the recordings to detect absence seizures, with NIH-funded validation showing 100% sensitivity and 91% specificity to video EEG for absence seizures greater than 7 seconds. Generates automated reports covering HV effort, time to first event, duration of event, and description of event, and is intended for use by pediatricians, primary care physicians, and child neurologists in clinical settings.

Quantifiable outcome

• 100% sensitive and 91% specific to vEEG for absence seizures > 7 seconds (NIH-funded validation study)
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Akili Interactive: Digital therapeutic for pediatric ADHD (EndeavorRx). Comparable as a software-driven pediatric neurology product targeting the same ADHD diagnostic and treatment pathway where Eysz positions its CAE-screening tool, though Akili delivers treatment rather than screening.
• Empatica: FDA-cleared wearable for neurological monitoring (epilepsy seizure detection via EpiMonitor). Comparable as a digital neurology device with regulatory clearance, real-world patient data flywheel, and overlap in pediatric/adolescent use cases, though Empatica uses wrist-worn biosensors rather than eye-tracking.
• Beacon Biosignals: AI-driven EEG analytics platform focused on neurological biomarker discovery and clinical trial endpoints. Highly comparable to Eysz in applying ML to brain signals for objective neurological assessment, though Beacon is positioned upstream in pharma trials rather than point-of-care.
• Zeto: Wireless EEG headset with cloud-based review and seizure detection. Comparable as a modernized EEG/neurological diagnostic aimed at clinical workflows with simpler hardware/software stack, competing for the same neurology clinic and pediatrician budgets.
• Rune Labs: Neurology data platform using brain signals and wearables for Parkinson's and other neurological conditions. Comparable as a digital biomarker / neurological monitoring company leveraging AI over continuous physiological recordings.

Emerging players

• Linus Health: Digital cognitive assessment platform using tablet-based tasks and AI for brain health. Comparable as a digital health company translating objective brain/cognitive measurement into clinical decision support, with some overlap in the pediatric/adult attention assessment space.
• Cumulus Neuroscience: Home-based, multi-modal CNS assessment platform for clinical trials combining EEG, voice, and cognitive tasks. Comparable in using non-invasive neurological biomarkers for objective assessment, overlapping with Eysz's clinical-research strategy.
• Neuronostics: EEG-based diagnostic algorithms for neurological conditions including epilepsy. Comparable as an algorithmic-only play using brain signal analysis, but without Eysz's pediatric point-of-care hardware positioning.

Broad incumbents

• Natus Medical: Long-standing neurology device manufacturer (EEG, neurodiagnostic systems). Comparable as a supplier of clinical neurology hardware to hospitals, representing both a potential integration partner and a competitor with established hospital sales channels.
• Wave Neuroscience: Established EEG-based assessment and neurofeedback provider with broader clinical footprint than Eysz. Comparable as a neurology assessment company using electrophysiology but operating at a much larger and more general scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds8 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EYSZ